Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiuxiang Zhu

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Biology & Therapy|May 24, 2005
Inhibiting phosphoinositide 3-kinasesYardena Samuels, Jiuxiang Zhu, Christoph Lengauer
International Journal of Cancer|October 23, 2004
Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9Haiming Ding, Chunhua Han, Jiuxiang Zhu, et al.
The Biochemical Journal|August 3, 2005
Neutrophil gelatinase-associated lipocalin as a survival factorZhimin Tong, Xuli Wu, Dmitriy Ovcharenko, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 4, 2006
A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growthJunan Li, Jiuxiang Zhu, W Scott Melvin, et al.
Journal of the National Cancer Institute|December 5, 2002
Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agentsJiuxiang Zhu, Xueqin Song, Ho-Pi Lin, et al.
BMC Microbiology|August 23, 2025
Evaluation of the new antimicrobial benziothiazolinone for management of fire blight disease of pearJiuxiang Zhu, Ling Cai, Yixin Wang, et al.
Genomics, Proteomics & Bioinformatics|April 25, 2026
PROBind: A Web Server for Prediction, Analysis, and Visualization of Protein-Protein and Protein-Nucleic Acid Binding ResiduesChaojin Wu, Fuhao Zhang, Pengzhen Jia, et al.
Chemmedchem|March 2, 2011
Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methodsJo-Anne Pinson, Oleg Schmidt-Kittler, Jiuxiang Zhu, et al.
Blood|September 30, 2004
A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanismAmy J Johnson, Lisa L Smith, Jiuxiang Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membraneDiana Mandelker, Sandra B Gabelli, Oleg Schmidt-Kittler, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|May 24, 2005
Inhibiting phosphoinositide 3-kinasesYardena Samuels, Jiuxiang Zhu, Christoph Lengauer
International Journal of Cancer|October 23, 2004
Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9Haiming Ding, Chunhua Han, Jiuxiang Zhu, et al.
The Biochemical Journal|August 3, 2005
Neutrophil gelatinase-associated lipocalin as a survival factorZhimin Tong, Xuli Wu, Dmitriy Ovcharenko, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 4, 2006
A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growthJunan Li, Jiuxiang Zhu, W Scott Melvin, et al.
Journal of the National Cancer Institute|December 5, 2002
Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agentsJiuxiang Zhu, Xueqin Song, Ho-Pi Lin, et al.
BMC Microbiology|August 23, 2025
Evaluation of the new antimicrobial benziothiazolinone for management of fire blight disease of pearJiuxiang Zhu, Ling Cai, Yixin Wang, et al.
Genomics, Proteomics & Bioinformatics|April 25, 2026
PROBind: A Web Server for Prediction, Analysis, and Visualization of Protein-Protein and Protein-Nucleic Acid Binding ResiduesChaojin Wu, Fuhao Zhang, Pengzhen Jia, et al.
Chemmedchem|March 2, 2011
Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methodsJo-Anne Pinson, Oleg Schmidt-Kittler, Jiuxiang Zhu, et al.
Blood|September 30, 2004
A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanismAmy J Johnson, Lisa L Smith, Jiuxiang Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membraneDiana Mandelker, Sandra B Gabelli, Oleg Schmidt-Kittler, et al.
Pageof 2